Oncology Institute, Inc. - Common Stock, $0.0001 Par Value Per Share (TOI)

CUSIP: 68236X100

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Common Stock, $0.0001 Par Value Per Share
Shares outstanding
99,175,922
Total 13F shares
23,473,725
Share change
+374,778
Total reported value
$38,730,078
Price per share
$1.65
Number of holders
37
Value change
-$1,269,944
Number of buys
25
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 68236X100?
CUSIP 68236X100 identifies TOI - Oncology Institute, Inc. - Common Stock, $0.0001 Par Value Per Share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Oncology Institute, Inc. - Common Stock, $0.0001 Par Value Per Share (TOI) as of Q4 2022

As of 31 Dec 2022, Oncology Institute, Inc. - Common Stock, $0.0001 Par Value Per Share (TOI) was held by 37 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,473,725 shares. The largest 10 holders included FMR LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), VANGUARD GROUP INC, BlackRock Inc., Redmile Group, LLC, GEODE CAPITAL MANAGEMENT, LLC, Triatomic Management LP, STATE STREET CORP, Prosight Management, LP, and NORTHERN TRUST CORP. This page lists 37 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.